ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
化工社オープンプロジェクト:[email protected]AIアクセス:llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.7.8
  1. ホーム
  2. /化合物

無水 ベタイン

Betaine

HCID 247
ノート反応
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
107-43-7
標準SMILES
C[N+](C)(C)CC(=O)[O-]
InChIKey
KWIUHFFTVRNATP-UHFFFAOYSA-N
分子式
C5H11NO2
平均分子量
117.15 g/mol
単同位体質量
117.07897859

概要

Glycine betaine is the amino acid betaine derived from glycine. It has a role as a fundamental metabolite. It is an amino-acid betaine and a glycine derivative. It is a conjugate base of a N,N,N-trimethylglycinium.

名称と識別子

優先名称
Betaine
IUPAC
2-(trimethylazaniumyl)acetate
現地名
無水 ベタイン
英語名
Betaine
分子式
C5H11NO2
分子量
117.15

名称と別名

betaine107-43-7glycine betaineoxyneurineTrimethylglycineAbrominelycineTrimethylglycocollGlycocoll betaineGlycylbetaine2-(trimethylazaniumyl)acetateRubrine C
名称をさらに表示
無水 ベタインα-アールレイングリシンベタインα-カルボキシラト-N,N,N-トリメチルメタンアミニウム(トリメチルアミニオ)アセタート2-オキソ-2-オキシラト-N,N,N-トリメチルエタンアミニウムアブロミンN,N-ジメチル-N-(カルボキシラトメチル)メタンアミニウム(トリメチルアミニオ)酢酸アニオンロラミンAMB-13ルブリンCカルボキシラトメチルトリメチルアンモニウムN,N,N-トリメチルアミニオアセタートN,N,N-トリメチルカルボキシラトメタンアミニウムグリシルベタイン(カルボキシラトメチル)トリメチルアミニウムカルボキシラト-N,N,N-トリメチルメタンアミニウムカルボキシラトメチルトリメチルアミニウムオキシニューリンリシン【ベタイン】BetainBETMethanaminiumANHYDROUS BETAINEBataineNMF-50
2-(Trimethylammonio)AcetateBetaine anhydrous(Trimethylammonio)acetateJortaineBETAINE, ANHYDROUStrimethylammonioacetateN,N,N-trimethylglycineTrimethylaminoacetic acid

物性

構造計算による物性

XLogP
0.5
極性表面積
40.1 Ų
水素結合供与体数
0
水素結合受容体数
2
回転可能結合数
1
重原子数
8
形式電荷
0
複雑度
87.6

実験および物理化学的性質

Chemical ClassesNitrogen Compounds -> Quaternary Amines
Cosmetics · 2 件

Cosmetic ingredients (Betaine) -> CIR (Cosmetic Ingredient Review)

Antistatic; Viscosity controlling

TasteSweet
Food AdditivesFLAVORING AGENT OR ADJUVANT -> FDA Substance added to food
Color/FormDeliquescent scales or prisms
Solubility · 6 件

Soluble

Solubility (g/100 g solvent): methanol, 55; ethanol, 8.7. Sparingly soluble in ether.

Slightly soluble in chloroform

In water, 6.11X10+5 mg/L at 19 °C

Very soluble

Soluble (in ethanol)

Dietary IngredientsBetaine
Human Drugs · 4 件

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

Animal DrugsPharmaceuticals -> Animal Drugs -> Approved in Taiwan

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 3 件

This chemical does not meet GHS hazard criteria for 90.4% (274 of 303) of all reports.

Not Classified

Aggregated GHS information provided per 303 reports by companies from 5 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory Information · 5 件

Chemical: Methanaminium, 1-carboxy-N,N,N-trimethyl-, hydroxide, innersalt

Regulation (EC) No 2015/2283 Article 10

Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)

REACH registered substance: Betaine (EC: 203-490-6)

Trimethylglycine: Does not have an individual approval but may be used under an appropriate group standard

Hazards Summary · 1 件

No evidence of mutagenicity; [HSDB] Does not cross the placenta well in animal experiments; [REPROTOX] Not irritating to skin or eyes of rabbits; Not sensitizing in guinea pig maximization test; No evidence of mutagenicity; [IUCLID] May cause irritation; [Alfa Aesar MSDS]

FDA Requirements · 2 件

The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl betaine hydrochloride, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. /Betaine hydrochloride/

Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses. A number of active ingredients have been present in OTC drug products for various uses, as described below. However, based on evidence currently available, there are inadequate data to establish general recognition of the safety and effectiveness of these ingredients for the specified uses: betaine hydrochloride is included in digestive aid drug products. /Betaine hydrochloride/

化学と産業

薬理情報

ATC Code · 2 件

A - Alimentary tract and metabolism

QA - Alimentary tract and metabolism

Pharmacodynamics · 1 件

Betaine decreases plasma homocysteine concentrations in homocystinuria cases caused by deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl). The decrease of homocysteine is estimated to be 20-30% of pre-treatment levels. Betaine supplementation in patients with homocystinuria also improves metabolic abnormalities in cerebrospinal fluid. Reports have shown that depending on the type of homocystinuria, the therapeutic effectiveness of betaine alone may be limited, insufficient to decrease total homocysteine levels and prevent clinical symptoms. In patients with homocystinuria due to cystathionine beta-synthase (CBS) deficiency, betaine should be used when serum total homocysteine levels remain high despite dietary therapy. Patients taking betaine for several years do not show evidence of tolerance. Also, betaine concentrations are not correlated with homocysteine concentrations. In patients with MTHFR deficiency and cbl defects, betaine may increase methionine and S-adenosyl methionine (SAM) plasma levels. Patients with CBS deficiency without a dietary restriction of methionine may accumulate excessive amounts of methionine. Clinical data shows that in patients with CBS deficiency, increased plasma methionine levels were associated with cerebral edema.

Mechanism of Action · 5 件

Homocystinuria is a hereditary disorder characterized by high levels of the amino acid homocysteine. This condition can be caused by deficiencies or defects in cystathionine beta-synthase (CBS), 5,10-methylenetetrahydrofolate reductase (MTHFR), and cobalamin cofactor metabolism (cbl). CBS converts homocysteine to cystathionine, and a deficiency in this enzyme can lead to an accumulation of homocysteine. MTHFR is responsible for producing 5-methyltetrahydrofolate, a methyl donor that participates in the conversion of homocysteine back to methionine; therefore, an MTHFR deficiency can also lead to homocystinuria. Additionally, a defect in cobalamin (vitamin B12) cofactor metabolism can lead to homocystinuria, since a metabolite of cobalamin (methylcobalamin) promotes the conversion of homocysteine to methionine. Betaine transfers a methyl group via the enzyme betaine homocysteine methyl transferase (BHMT), converting homocysteine back into methionine and dimethylglycine (DMG). In patients with homocystinuria, betaine reduces homocysteine levels and improves health outcomes.

関連反応

0 件
反応記録を作成

現在のフィルター条件では反応記録がありません。

化合物ノート

読み込み中…

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート

データベース識別子

CAS
107-43-7
PubChem CID
247
DTXSID
DTXSID8022666
ChEMBL
CHEMBL1182、CHEMBL95889
ChEBI
CHEBI:17750
UNII
3SCV180C9W
EC Number
203-490-6
Nikkaji
J5.058J
Melting Point · 2 件

301-305°C

Decomposes around 293 °C

Vapor Pressure0.00000053 [mmHg]
Physical Description · 3 件

Liquid; Dry Powder

Deliquescent solid; [Merck Index] Powder; [Alfa Aesar MSDS]

Free-flowing, white crystals; Savoury

物理化学的性質

融点
310 °C · 310 °C (dec.)
沸点
218.95 °C · 218.95°C (rough estimate)
比重(密度)
1 g/mL · 1.00 g/mL at 20 °C
蒸気圧
0.05 Pa · 0.05Pa at 25℃
屈折率
1.4206 · 1.4206 (estimate)
FEMA
4223 · 4223 | BETAINE
貯蔵温度
2 · 2-8°C
溶解性
0.1 g/mL、透明 · メタノール: 0.1 g/mL、透明
外見
結晶または結晶性粉末
酸解離定数(Pka)
1.83 · 1.83(at 0℃)
色
無色
臭い (Odor)
無味な
由来生物
sugar beets
水溶解度
160 g/100mL · 160g/100mL
Merck
14 · 14,1179
JECFA Number
2265 · 2265
BRN
3537113 · 3537113
安定性
安定。吸湿性。強力な酸化剤とは相容れない。
主な用途
フレーバーそして香料
化粧品成分の機能
皮膚コンディショニング - 保湿剤保湿剤ヘアコンディショニング
InChI
1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3
InChIKey
KWIUHFFTVRNATP-UHFFFAOYSA-N
SMILES
C[N+](C)(C)CC([O-])=O
LogP
-3.1 at · -3.1 at 20℃
CAS データベース
107 · 107-43-7(CAS DataBase Reference)
NISTの化学物質情報
1 · Methanaminium, 1-carboxy-n,n,n-trimethyl-, hydroxide, inner salt(107-43-7)
EPAの化学物質情報
Betaine (107-43-7)
Absorption
0.05 at · ≤0.05 at 280nm in methanol at 1M≤0.09 at 260nm in methanol at 1M
EPA Safer ChemicalChemical: Betaine
Hazard Classes and CategoriesNot Classified

安全と保護具

Storage ConditionsStore below 40 °C (104 °F), preferably between 15 and 30 °C (59 and 86 °F), unless otherwise specified by the manufacturer . Protect from moisture .
Disposal Methods · 1 件

SRP: At the time of review, criteria for land treatment or burial (sanitary landfill) disposal practices are subject to significant revision. Prior to implementing land disposal of waste residue (including waste sludge), consult with environmental regulatory agencies for guidance on acceptable disposal practices.

毒性情報

Interactions · 4 件

The aim of this study was to assess the pharmacokinetics of orally administered betaine and its acute effect on plasma total homocysteine (tHcy) concentrations. Healthy volunteers (n = 10; 3 men, 7 women) with normal body weight (mean + or - SD, 69.5 + or - 17.0 kg), 40.8 + or - 12.4 yr old, participated in the study. The betaine doses were 1, 3, and 6 g. The doses were mixed with 150 mL of orange juice and ingested after a 12-hr overnight fast by each volunteer according to a randomized double-blind crossover design. Blood samples were drawn for 24 hr and a 24-hr urine collection was performed. Orally administered betaine had an immediate and dose-dependent effect on serum betaine concentration. Single doses of 3 and 6 g lowered plasma tHcy concentrations (P = 0.019 and P < 0.001, respectively), unlike the 1-g dose. After the highest dose, the concentrations remained low during the 24 hr of monitoring. The change in plasma tHcy concentration was linearly associated with betaine dose (P = 0.006) and serum betaine concentration (R2 = 0.17, P = 0.025). The absorption and elimination of betaine were dose dependent. The urinary excretion of betaine seemed to increase with an increasing betaine dose, although a very small proportion of ingested betaine was excreted via urine. In conclusion, a single dose of orally administered betaine had an acute and dose-dependent effect on serum betaine concentration and resulted in lowered plasma tHcy concentrations within 2 hr in healthy subjects.

The prophylactic efficiency of taurine or betaine pretreatment for the prevention of peroxidative changes induced by lipopolysaccharide treatment in the rat liver was investigated ... Lipopolysaccharide (10 mg/kg intraperitoneally) was given to rats pretreated with taurine (1.5%, w/v) or betaine (1.5%, w/v) in drinking water for 4 weeks and plasma transaminase activities as well as hepatic malondialdehyde, diene conjugate (DC), glutathione, alpha-tocopherol and ascorbic acid levels, and superoxide dismutase (SOD) and glutathione peroxidase activities were determined ... Significant increases in plasma transaminase activities and hepatic malondialdehyde and DC levels and decreases in hepatic glutathione and alpha-tocopherol levels and SOD and glutathione peroxidase activities were observed 6 h after lipopolysaccharide treatment. This treatment did not alter ascorbic acid levels in the liver compared with controls. Taurine or betaine pretreatment in lipopolysaccharide-injected rats caused significant decreases in plasma transaminase activities and hepatic malondialdehyde and DC levels, and significant increases in glutathione and alpha-tocopherol (not betaine) levels without changing ascorbic acid levels and SOD and glutathione peroxidase activities in the liver ... /According to the authors/ taurine or betaine pretreatment was effective in the prevention of lipopolysaccharide-induced hepatotoxicity and prooxidant status.

Concomitant use of betaine and folic acid may be additive with regard to the possible lowering of serum homocysteine levels.

... Remethylation of homocysteine to methionine can occur through either the folate-dependent methionine synthase pathway or the betaine-dependent betaine-homocysteine methyltransferase pathway. The relevance of betaine as a determinant of fasting total homocysteine (tHcy) is not known, nor is it known how the 2 remethylation pathways are interrelated ... The objectives of the study were to examine the relation between plasma betaine concentration and fasting plasma tHcy concentrations and to assess the effect of folic acid supplementation on betaine concentrations in healthy subjects ... A double-blind randomized trial of 6 incremental daily doses of folic acid (50-800 ug/day) or placebo was carried out in 308 Dutch men and postmenopausal women (aged 50 to 75 yr). Fasted blood concentrations of tHcy, betaine, choline, dimethylglycine, and folate were measured at baseline and after 12 wk of vitamin supplementation ... Concentrations of tHcy were inversely related to the betaine concentration (r = -0.17, P < 0.01), and the association was independent of age, sex, and serum concentrations of folate, creatinine, and cobalamin. Folic acid supplementation increased betaine concentration in a dose-dependent manner (P for trend = 0.018); the maximum increase (15%) was obtained at daily doses of 400 to 800 ug/day ... /The authors condluded/ the plasma betaine concentration is a significant determinant of fasting tHcy concentrations in healthy humans. Folic acid supplementation increases the betaine concentration, which indicates that the 2 remethylation pathways are interrelated.

Hepatotoxicity · 1 件

In small, open label trials of betaine therapy for homocystinuria as well as in small controlled trials of betaine in other conditions (Alzheimer disease, nonalcoholic steatohepatitis), serum enzyme elevations and clinically apparent liver injury were not reported. Indeed, in some studies, betaine has been associated with significant declines in preexisting serum enzyme elevations in a proportion of patients with nonalcoholic fatty liver disease.

Environmental Fate · 3 件

TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 3(SRC), determined from a water solubility of 611,000 mg/L at 19.3 °C(2) and a regression-derived equation(3), indicates that betaine is expected to have very high mobility in soil(SRC). The estimated pKa of betaine, an inner salt, is 2.38(4). Volatilization of betaine from moist soil surfaces is not expected to be an important fate process(SRC) because ionic compounds do not volatilize. Betaine is not expected to volatilize from dry soil surfaces(SRC) based upon an estimated vapor pressure of 1.4X10-8 mm Hg(SRC), determined from a fragment constant method(5). No information on the aerobic biodegradation of betaine was located; however, the mineralization of alkyl betaine surfactants is considerable (>60% BODT reached in 28-day screening tests(6,7)) indicating that it is likely that betaine is also readily mineralized(SRC). Betaine is expected to biodegrade under anaerobic conditions as well based on data indicating that it is removed during anaerobic sewage treatment(8).

AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 3(SRC), determined from a water solubility of 611,000 mg/L at 19.3 °C(2) and a regression-derived equation(3), indicates that betaine is not expected to adsorb to suspended solids and sediment(SRC). An estimated pKa of 2.38(4) indicates betaine, will exist entirely as an inner salt at pH values of 5 to 9 and therefore volatilization from water surfaces will not occur as ionic compounds do not volatilize. According to a classification scheme(5), an estimated BCF of 0.3(SRC), from its water solubility(2) and a regression-derived equation(6), suggests the potential for bioconcentration in aquatic organisms is low(SRC). No information on the aerobic biodegradation of betaine was located; however, the mineralization of alkyl betaine surfactants is considerable (>60% BODT reached in 28-day screening tests(7,8)) indicating that it is likely that betaine is also readily mineralized(SRC). Betaine is expected to biodegrade under anaerobic conditions as well based on data indicating that it is removed during anaerobic sewage treatment(9).

ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), betaine, which has an estimated vapor pressure of 1.4X10-8 mm Hg at 25 °C(SRC), determined from a fragment constant method(2), is expected to exist solely in the particulate phase in the ambient atmosphere. Particulate-phase betaine may be removed from the air by wet or dry deposition(SRC). Betaine does not contain chromophores that absorb at wavelengths >290 nm and therefore is not expected to be susceptible to direct photolysis by sunlight(3).

Food Survey Values · 1 件

The betaine concentration of over 400 foods in the U.S. was measured. Concentrations ranged from 0.3 to 1.9 mg/100 g food for 26 dairy and egg products, 0.4 to 28.8 mg/100 g food for 16 spices, 0 to 1.8 mg/100 g food for 7 samples of fats and oils, 1.8 to 23.3 mg/100 g food for 16 samples of chicken and turkey, 2.1 to 10.4 mg/100 g for 18 sausage and luncheon meats, 0.5 to 1396.1 mg/100 g for 15 samples of breakfast cereals, 0.1 to 0.8 mg/100 g for 35 fruits, 0.2 to 4.2 mg/100 g food for 10 pork product samples, 0.1 to 808.6 mg/100 g food for 62 vegetable products with beets and spinach containing significantly more betaine than other vegetables, 0.3 to 11.2 mg/100 g food for 12 nut and seed products, 6.3 to 12.8 mg/100 g food for 15 beef products, 0.1 to 8.1 mg/100 g food for 12 beverages, 2.1 to 62.1 mg/100 g food for 11 finfish and shellfish products, 0.1 to 39.6 mg/100 g food for 21 legumes and legume products, 7.6 to 33.9 mg/100 g food for 4 lamb, veal and game samples, 0.4 to 244.1 mg/100 g food for 43 baked products, 0.1 to 6.1 mg/100 g food for 20 sugars and sweets products, 0.3 to 1506.8 for 13 samples of cereal grains and pasta products, 0.5 to 98.2 mg/100 g for 50 samples of fast foods, 0.1 to 21.6 mg/100 g for 10 snacks (pretzels were 295.1 mg/100 g food)(1).

Milk ConcentrationsENVIRONMENTAL: Concentrations of betaine in 5 samples of milk ranged from 0.6 to 1.9 mg/100 g milk(1).
Toxicity Summary · 2 件

The CIR Expert Panel concluded that the eleven alkyl betaines listed below are safe in the present practices of use and concentration in cosmetics, when formulated to be non-irritating...Betaine...

Safe for use in cosmetics, with qualifications

Effluent ConcentrationsBetaine was detected in the effluent of processes using sugar-beet molasses as a substrate at concentrations up to 4.5 g/dm-3(1).
Soil Adsorption/Mobility · 1 件

The Koc of betaine is estimated as 3(SRC), using a water solubility of 611,000 mg/L at 19.3 °C(1) and a regression-derived equation(2). According to a classification scheme(3), this estimated Koc value suggests that betaine is expected to have very high mobility in soil. The estimated pKa of betaine, an inner salt, is 2.38(4).

Natural Pollution SourcesBetaine is widely distributed in both plants and animals(1) as a nonproteinogenic amino acid(2).
Artificial Pollution SourcesBetaine's production and use in soldering, resin curing fluxes, organic synthesis and in the treatment of homocystinuria(1) and as a lipotrophic drug(2) may result in its release to the environment through various waste streams(SRC).
Environmental Biodegradation · 2 件

AEROBIC: No data on the aerobic biodegradation of betaine was located however, amphoteric surfactants based on the betaine structure have been shown to be mineralized to a significant extent. For example, C12-C14 alkyl betaine surfactants were shown to be readily biodegradable in 28-day closed bottle screening tests reaching >60% of the theoretical oxygen demand over this period(1,2).

ANAEROBIC: Betaine was nearly completely degraded in two full-scale anaerobic treatment plants(1).

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Betaine

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

法規制情報

FDA Requirements · 2 件

The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed prescription drug products, incl betaine hydrochloride, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. /Betaine hydrochloride/

Drug products containing certain active ingredients offered over-the-counter (OTC) for certain uses. A number of active ingredients have been present in OTC drug products for various uses, as described below. However, based on evidence currently available, there are inadequate data to establish general recognition of the safety and effectiveness of these ingredients for the specified uses: betaine hydrochloride is included in digestive aid drug products. /Betaine hydrochloride/

安全データ

F
3-10
wgk
3
tsca
TSCA listed
rtecs
DS5900000
hs_code
29239000
risk_code
20/21/22-36/37/38
化審法
(2)-1291, (2)-2709
hazard_code
Xn
safety_code
24/25-36-26
ストレージクラス
11 - Combustible Solids
有毒物質データの
107-43-7(Hazardous Substances Data)

Betaine acts as metabolic intermediate in transmethylating processes (creatine and methionine synthesis).

Betaine acts as a methyl group donor in the remethylation of homocysteine to methionine in patients with homocystinuria. This reduces toxic concentrations of homocysteine, usually to 20 to 30% or less of pretreatment concentrations.

Betaine or trimethylglycine is a quarternary ammonium compound that was first discovered in the juice of sugar beets (Beta vulgaris). Betaine is a metabolite of choline ... and is a substrate in one of the two recycling pathways that convert homocysteine to L-methionine. The other and principal recycling reaction is catalyzed by the enzyme methionine synthase and uses methylcobalamin as a cofactor and 5-methyltetrahydrofolate as a cosubstrate.

Betaine-homocysteine methyltransferase (BHMT) is a zinc metalloenzyme which catalyzes the transfer of a methyl group from betaine to homocysteine in the formation of methionine. BHMT is found in the liver and kidneys and may also exist in brain tissue. Betaine acts to lower homocysteine levels in some with primary hyperhomocysteinemia/homocystinuria via this enzyme.

Biological Half-Life · 1 件

In healthy volunteers (n=12) given 50 mg/kg of betaine, the elimination half-life was 14.38 h. In volunteers given 100 mg/kg/day of betaine for 5 days, the distribution half-life was significantly longer, suggesting that the transport and redistribution processes of betaine were saturated.

Metabolism/Metabolites · 3 件

Betaine is catabolized mainly in the mitochondria of liver and kidney cells. The transmethylation of betaine via betaine homocysteine methyl transferase (BHMT) leads to the formation of dimethylglycine.

Betaine is absorbed from the small intestines into the enterocytes. It is released by the enterocytes into the portal circulation which carries it to the liver where there is significant first-pass extraction and first-pass metabolism of betaine. The principal metabolic reaction is the transfer of a methyl group from betaine to homocysteine via the enzyme betaine-homocysteine methyltransferase. The products of the reaction are L-methionine and dimethylglycine. Betaine hydrochloride is converted to betaine in the alkaline environment of the small intestine.

/Betaine/ is a metabolite of choline ...

FDA Pharmacological Classification · 6 件

3SCV180C9W

BETAINE

Mechanisms of Action [MoA] - Methylating Activity

Established Pharmacologic Class [EPC] - Methylating Agent

Betaine is a Methylating Agent. The mechanism of action of betaine is as a Methylating Activity.

BETAINE

MeSH Pharmacological Classification · 2 件

Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion.

Endogenous factors or drugs that increase the transport and metabolism of LIPIDS including the synthesis of LIPOPROTEINS by the LIVER and their uptake by extrahepatic tissues.

Absorption, Distribution and Excretion · 6 件

Betaine is rapidly absorbed and distributed. In healthy volunteers (n=12) given 50 mg/kg of betaine, the Cmax, tmax and AUC0,∞ were 0.939 mmol/L, 0.90 h and 5.52 mmol⋅h/L, respectively. No significant changes in absorption kinetics were observed after repeated betaine administration (100 mg/kg/day for 5 days). The absolute bioavailability of betaine anhydrous has not been determined.

Betaine is mainly eliminated by metabolism. With a slow elimination rate and assuming 100% bioavailability, the renal clearance of betaine is negligible (5% of total body clearance).

Based on a study done on healthy volunteers (n=12) given 50 mg/kg of betaine, the volume of distribution was 1.3 L/kg.

Based on a study done on healthy volunteers (n=12) given 50 mg/kg of betaine, total oral plasma drug clearance was 0.084 L/h⋅kg.

Betaine is absorbed from the small intestines into the enterocytes. It is released by the enterocytes into the portal circulation which carries it to the liver where there is significant first-pass extraction and first-pass metabolism of betaine. The principal metabolic reaction is the transfer of a methyl group from betaine to homocysteine via the enzyme betaine-homocysteine methyltransferase. The products of the reaction are L-methionine and dimethylglycine. Betaine hydrochloride is converted to betaine in the alkaline environment of the small intestine.

It is not known whether betaine is distributed into breast milk. However, its metabolic precursor, choline, is found in human breast milk in high concentrations .

用途と製造

Uses · 6 件

CIR ingredient: Betaine

Occurs naturally in plants and animals; Used in the treatment of homocystinuria; [Merck Index] Used in soldering and resin curing fluxes, in organic synthesis, and in fisheries (promotes fish survival and aids transfer of salmon and trout from freshwater to seawater); [HSDB]

Soldering [Category: Heat or Machine]

In soldering, resin curing fluxes, organic synthesis; in treatment of homocystinuria

Lipotropic drug

Gastric acidifier /Betaine hydrochloride/

U.S. Production2023: 100,000 - <250,000 lb
Consumer UsesOther
Industry UsesOther
Methods of ManufacturingFour basic processes are suitable for the production of amino acids: chemical synthesis (including asymmetric synthesis), extraction, fermentation, and enzymatic routes. /Amino acids/
Formulations/Preparations · 4 件

Oral: For solution: 1 g/level scoopful Cystadane, (Orphan Medical)

Oral: 1 gram per 1.7 mL of powder (one scoopful) (Rx) (Cystadane).

Cystadane (betaine anhydrous for oral solution)

Betaine, in the form of a white, granular, hygroscopic powder referred to as anhydrous betaine ...

Household ProductsInformation on 44 consumer products that contain Betaine in the following categories is provided:
Use Classification · 6 件

EPA Safer Chemical Functional Use Classes -> Processing Aids and Additives

Safer Chemical Classes -> Green half-circle - The chemical is expected to be of low concern

Flavoring Agents -> JECFA Flavorings Index

Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes

Pharmaceuticals -> Animal Drugs -> Approved in Taiwan

Cosmetics -> Antistatic; Viscosity controlling

General Manufacturing Information · 2 件

Printing Ink Manufacturing

Methanaminium, 1-carboxy-N,N,N-trimethyl-, inner salt: ACTIVE

応用分野 · 5 件

解説① 一つの分子内に第四級アンモニウム陽イオンとカルボン酸陰イオンとをもつ分子内塩型の化合物の一般名.溶液中でも結晶状態でも,両性イオンとして存在する.第四級アンモニウム型の陽イオン構造と,酸性の陰イオン構造との両性中心をもつ化合物を,より広い意味でベタインということもある.リン化合物においても使われる.② 代表的なベタイン構造を有する化合物,(CH3)3N+CH2COO-の名称.

用途有機合成原料。

説明Betaine is a natural compound extracted from Beta vulgaris, widely present in both leaves and roots. Within plants, betaine is synthesised through a two-step oxidation of choline within chloroplasts. The first step converts choline into betaine aldehyde, a rate-limiting step catalysed by choline monooxygenase. The second step converts betaine aldehyde to betaine, catalysed by betaine aldehyde dehydrogenase [1]. It possesses certain pharmacological activities and may be employed to treat deficiencies or defects in specific enzymes leading to hyperhomocysteinemia in blood and urine. This medication facilitates the removal of excess homocysteine from the body.[1] TAKABE T, TANAKA Y, TAKABE T. CHAPTER 2:Betaine in Sugar Beet[C]. 2015: 0. DOI:10.1039/9781782628446-00009.

使用betaine is a surfactant, humectant, and excellent skin conditioner. It is also used to build product viscosity and as a foam booster. It is found mostly in skin cleansers, shampoos, and bath products.

一般的な説明Betaine also called trimethylglycine or N,N,N triethylammonium acetate, is an analog of glycine with three methyl groups. It is highly compatible with polymerase chain reaction (PCR) buffer mixture. Betaine is a PCR enhancing reagent that is widely used for improving the yield and specificity of PCR products, especially during the PCR amplification of targets rich in GC content or those that form secondary structures resulting in poor yield. Betaine facilitates DNA strand separation and manages the DNA melting temperature (Tm) difference between the GC and AT pairs in DNA. It stabilizes the ds DNA by equalizing the contribution of GC- and AT-base pairs. Betaine has been broadly used to optimize multiplex and ‘long and accurate′ polymerase chain reaction (LA-PCR). The addition of 1.0-1.7 M aqueous betaine to a PCR mixture has been reported to reduce the base pair composition dependence on DNA strand melting.

調製方法 · 1 件

純化方法Crystallise betaine from aqueous EtOH or EtOH/Et2O. The monohydrate loses H2O above 100o. Betaine undergoes internal alkylation to methyl dimethylaminoacetate Purification of Biochemicals — Amino Acids and Peptides above its melting point. It is also prepared by treating the hydrochloride (below) with silver oxide and recrystallising from EtOH/Et2O. [Edsall J Am Chem Soc 66 1767 1943, Leifer & Lippincott J Am Chem Soc 79 5098 1957, for pK see Grob et al. Chem and Ind (London) 1222 1955, Beilstein 4 III 1127, 4 IV 2369.]

上流・下流製品情報

上流原料

トリメチルアミン水溶液 3 0 %Trimethylamine,aqueous solutionクロロ酢酸ナトリウムコリン クロリド次亜塩素酸ナトリウム亜塩素酸ナトリウムアセトニトリル2,2,6,6-テトラメチルピペリジン1-オキシル フリーラジカル

下流製品

L-カルニチンチオベタイン

サプライヤー100 社

国药集团化学试剂有限公司86-21-63210123 · [email protected]
北京华美互利生物化工010-56205725 · [email protected]
梯希爱(上海)化成工业发展有限公司021-67121386 · [email protected]
上海阿拉丁生化科技股份有限公司400-6206333 13167063860 · [email protected]
INTATRADE GmbH+49 3493/605464 · [email protected]
爱斯特(成都)生物制药股份有限公司+86-28-85122536 85324413 · [email protected]
上海如吉生物科技发展有限公司+86-21-65211385-8001 36031160 · [email protected]
上海将来实业股份有限公司400-0066400 13621662912 · [email protected]
Syntechem Co.,Ltd[email protected]
上海迈瑞尔生化科技有限公司4006356688 18621169109 · [email protected]
武汉易泰科技有限公司上海分公司18930552037 · [email protected]
大连美仑生物技术有限公司0411-62910999 13889544652 · [email protected]
阿法埃莎(中国)化学有限公司400-6106006 · [email protected]
太原市瑞和丰科贸有限公司+86 351 7031519 · [email protected]
安耐吉化学&3A(安徽泽升科技股份有限公司)400-0056266 · [email protected]
河北鸿韬生物工程有限公司15512737321 · [email protected]
上海瀚鸿科技股份有限公司021-54306202 13764082696 · [email protected]
天津万象恒远科技有限公司15722085254 · [email protected]
成都普菲德生物技术有限公司028-82610909 13388174823 · [email protected]
Pure Chemistry Scientific Inc.001-857-928-2050 or 1-888-588-9418 · [email protected]
深圳虹彩祥根生物科技有限公司+86-0755-89668383 · [email protected]
MedChemexpress LLC021-58955995 · [email protected]
合肥天健化工有限公司551-65418679 15856988503;15837135945 · [email protected]
武汉丰泰威远科技有限公司027-87465837 19945049750 · [email protected]
孝感深远化工有限公司15527621225; 15527621225 · [email protected]
石家庄可辰化工有限公司18633820607 18633820607 · [email protected]
山东西亚化学有限公司13355009207 13355009207 · [email protected]
四川库利南科技有限公司400-1166-196 18981987031 · [email protected]
天津希恩思生化科技有限公司400 638 7771 · [email protected]
湖南汇百侍生物科技有限公司0731-85526065 13308475853 · [email protected]
成都健腾生物技术有限公司86-28-85159085 · [email protected]
斯百全化学(上海)有限公司021-021-021-67601398-809-809-809 15221380277 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
艾科试剂4008-755-333 18080918076 · [email protected]
成都锦然生物科技有限公司028-83311324 1278112614 · [email protected]
上海思域化工科技有限公司86-21-34053660 · [email protected]
赛默飞世尔科技(中国)有限公司800-810-5118 · [email protected]
北京伊诺凯科技有限公司400-810-7969 010-59572699 · [email protected]
TCI AMERICA800-4238616 · [email protected]
TOKYO CHEMICAL INDUSTRY CO., LTD.03-36680489 · [email protected]
TCI Europe320-37350700 · [email protected]
上海贤鼎生物科技有限公司4009209199 · [email protected]
深圳康特腾科技有限公司86-0755-86635001 · [email protected]
南京杜莱生物技术有限公司025-84699383-8003;025-846993838003-8003 18013301590 · [email protected]
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
成都瑞芬思德丹生物科技有限公司2355253622; 18981954830 · [email protected]
上海倍卓生物科技有限公司021-61119791,13386096464 · [email protected]
上海湄水化工科技有限公司021-60549325 18616193163
上海将来实业股份有限公司021-61552785 · [email protected]
HBCChem, Inc.+1-510-219-6317 · [email protected]

補足説明

定義本品は、次の化学式で表される両性化合物(分子内塩)である。

定義ChEBI: The amino acid betaine derived from glycine.